Genomic Signatures from Clinical Tumor Sequencing in Patients with Breast Cancer Having Germline BRCA1/2 Mutation
Cancer Research and Treatment. 2023;55(1):155-166 
Rucaparib in patients presenting a metastatic breast cancer with Homologous Recombination Deficiency, without germline BRCA1/2 mutation
. 2021;
BRCA1/2 Mutation Detection in the Tumor Tissue from Selected Polish Patients with Breast Cancer Using Next Generation Sequencing
Genes. 2021;12(4):519
Identification of genomic signatures in circulating tumor cells from breast cancer
International Journal of Cancer. 2015;137(2):332-344
Risk of having BRCA1 mutation in high-risk women with triple-negative breast cancer: a meta-analysis
Clinical Genetics. 2013;85(1):43-48
Oncotype Dx recurrence score among BRCA1/2 germline mutation carriers with hormone receptors positive breast cancer
International Journal of Cancer. 2017;140(9):2145-2149
Development of Breast Cancer in a 21-Year-Old Childhood Wilms' Tumor Survivor With a BRCA1 2634delC Mutation
Clinical Breast Cancer. 2011;11(4):268-269
Characteristics of breast cancer patients tested for germline BRCA1/2 mutations by next-generation sequencing in Ramathibodi Hospital, Mahidol University
. 2021;
An 8-lncRNA signature predicts the survival of triple-negative breast cancer patients without germline BRCA1/2 mutation
. 2021;
Absence of loss of heterozygosity of BRCA1 in a renal tumor from a BRCA1 germline mutation carrier
Familial Cancer. 2012;12(1):125-127